Myriad Genetics

Myriad Genetics, Inc.
Company typePublic
NasdaqMYGN
S&P 600 Component
IndustryHealthcare
Molecular Diagnostics
Biotechnology
Precision Medicine
Founded1991; 33 years ago (1991), in Salt Lake City, Utah, United States
FounderMark Skolnick Peter Meldrum
HeadquartersSalt Lake City, Utah
Key people
Paul J. Diaz (president and CEO)
Jerry Lanchbury (CSO)
Walter Gilbert (director and vice chair)
RevenueIncrease $690.6 Million(2021)[1]
Number of employees
2,600[2]
Websitemyriad.com

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.

  1. ^ "Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives". 24 February 2021.
  2. ^ "Myriad's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile".